Suppr超能文献

使用西门子散射浊度仪的标准化物质对胱抑素 C 进行重新校准。

Recalibration of cystatin C using standardized material in Siemens nephelometers.

机构信息

University of Rochester Medical Center, Box 777, 601 Elmwood Avenue, Rochester, NY, USA.

Johns Hopkins Bloomberg School of Public Health, Baltimore, MD, USA.

出版信息

Pediatr Nephrol. 2020 Feb;35(2):279-285. doi: 10.1007/s00467-019-04389-2. Epub 2019 Nov 3.

Abstract

BACKGROUND

Cystatin C is a key GFR biomarker. Recently, Siemens recalibrated the assay based on certified reference material ERM-DA471/IFCC. The NIH-funded longitudinal chronic kidney disease in children (CKiD) study has > 3000 cystatin C measurements based on a pre-IFCC calibrator provided by Siemens. Since cystatin C values for CKiD are now standardized to IFCC certified reference material, it is important to relate the IFCC-calibrated results to the previous values so that there are no discontinuous results.

METHODS

We diluted cystatin C ERM-DA471/IFCC (5.48 mg/L) into buffer and compared results with predicted ones. We then updated the cystatin C application on our BN II nephelometer to provide results based on pre-IFCC and IFCC calibrations of CKiD specimens simultaneously. We assayed 51 previously analyzed sera and 62 fresh additional specimens.

RESULTS

The predicted concentrations from the IFCC standard were consistently 17% higher than the measured values using the pre-IFCC calibration (y = 1.1686x). Similarly, the re-run and fresh sample concentrations were 17% higher via the IFCC calibration than by the pre-IFCC calibration (y = 1.168x). There was very high reliability in the measurements using the previous calibration for re-run specimens (0.99) and for 33 pristine specimens using IFCC calibration (0.99).

CONCLUSIONS

We confirm the recalibration proposed by Siemens. To convert pre-IFCC results to IFCC-calibrated concentrations, the value is multiplied by 1.17. Conversely, one divides IFCC-calibrated results by 1.17 to estimate GFR via previously published pre-IFCC CKiD eGFR equations. For older adolescents, cystatin C has already been standardized and can be directly applied to the CKD-EPI equations.

摘要

背景

半胱氨酸蛋白酶抑制剂 C 是肾小球滤过率(GFR)的重要生物标志物。最近,西门子公司基于认证参考物质 ERM-DA471/IFCC 对该检测方法进行了重新校准。美国国立卫生研究院(NIH)资助的儿童慢性肾脏病纵向研究(CKiD)项目包含超过 3000 项基于西门子提供的预 IFCC 校准物的半胱氨酸蛋白酶抑制剂 C 测量值。由于 CKiD 的半胱氨酸蛋白酶抑制剂 C 值现在已标准化为 IFCC 认证参考物质,因此将 IFCC 校准结果与之前的值相关联非常重要,以免出现不连续的结果。

方法

我们将 ERM-DA471/IFCC(5.48mg/L)半胱氨酸蛋白酶抑制剂 C 稀释至缓冲液中,并将结果与预测值进行比较。然后,我们更新了 BN II 散射浊度计上的半胱氨酸蛋白酶抑制剂 C 应用程序,以便同时提供基于 CKiD 标本预 IFCC 和 IFCC 校准的结果。我们检测了 51 份先前分析的血清和 62 份新鲜附加标本。

结果

使用预 IFCC 校准测量时,IFCC 标准预测的浓度始终比实测值高 17%(y=1.1686x)。同样,使用 IFCC 校准的重新检测和新鲜样本浓度比使用预 IFCC 校准的浓度高 17%(y=1.168x)。使用之前的校准对重新检测的标本进行测量具有非常高的可靠性(0.99),对使用 IFCC 校准的 33 份原始标本进行测量也具有非常高的可靠性(0.99)。

结论

我们证实了西门子公司提出的重新校准。要将预 IFCC 结果转换为 IFCC 校准浓度,将值乘以 1.17。相反,要通过之前发表的预 IFCC CKiD eGFR 方程估算 GFR,可以将 IFCC 校准的结果除以 1.17。对于年龄较大的青少年,半胱氨酸蛋白酶抑制剂 C 已经标准化,可以直接应用于 CKD-EPI 方程。

相似文献

2
GFR Estimation After Cystatin C Reference Material Change.胱抑素C参考物质变更后的肾小球滤过率估算
Kidney Int Rep. 2020 Dec 7;6(2):429-436. doi: 10.1016/j.ekir.2020.11.028. eCollection 2021 Feb.
10
[Estimation of glomerular filtration rate using cystatin C].[使用胱抑素C估算肾小球滤过率]
Ann Biol Clin (Paris). 2019 Aug 1;77(4):375-380. doi: 10.1684/abc.2019.1456.

引用本文的文献

本文引用的文献

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验